FundedIQ
Biotechnology

Molecular Gate: Funding, Investors & Team (Sep 2026)

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.

molecular-gate.com LinkedIn Barcelona, Spain 1-10 employees
Biotechnology Life Science Pharmaceutical
Total raised
$530k
Rounds
1
Latest
Seed
Mar 2026

Molecular Gate has raised $530k across 1 funding round on record, the most recent a Seed of $530k announced in Mar 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Molecular Gate Company Profile and Key Stats

Total funding raised
$530k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$530k in Mar 2026
Employees
1-10
reported band
Headquarters
Barcelona, Spain

Latest funding round on record: Mar 2026.

Molecular Gate Funding Rounds

Date
Round
Amount
Seed
$530k

Molecular Gate Founders and Leadership Team

Name
Role
Contact
Jordi Mata Fink
Founder
Locked

Contact details for the Molecular Gate team: 1 has a LinkedIn profile.

Start 14-day free trial →

Molecular Gate Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
1,049
$3.1M
16,485
$3.1M

Molecular Gate's latest round of $530k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Molecular Gate in Biotechnology and Barcelona

Companies Similar to Molecular Gate

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…

Undisclosed round $2.8M

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…

Undisclosed round $8.1M

Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…

Series B $86.6M

IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…

Undisclosed round $2.9M

Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…

Undisclosed round $2.9M

Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…

Undisclosed round $1.4M

Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…

Undisclosed round $34.9M

Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…

Undisclosed round $2.3M

Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…

Undisclosed round $530k

Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…

Undisclosed round $23.1M

In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…

Series B $40.6M

Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of…

Undisclosed round $17.7M

Molecular Gate Funding FAQs

What does Molecular Gate do?

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.

How much funding has Molecular Gate raised?

Molecular Gate has raised $530k across 1 round on record. The most recent is a Seed of $530k announced in Mar 2026.

When did Molecular Gate last raise funding?

Molecular Gate's most recent funding round on record is a Seed of $530k, announced in Mar 2026.

Who founded Molecular Gate?

FundedIQ lists Jordi Mata Fink (Founder) at Molecular Gate.

Where is Molecular Gate headquartered?

Molecular Gate is based in Barcelona, Catalonia, Spain.

How many employees does Molecular Gate have?

Molecular Gate is in the 1-10 employee band.

How does Molecular Gate's funding compare to other Biotechnology startups?

Molecular Gate's latest round of $530k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Molecular Gate Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Molecular Gate is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.